Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "shareholders"

253 News Found

Vikas Lifecare acquires 22.04% stake in Advik Laboratories
News | July 15, 2021

Vikas Lifecare acquires 22.04% stake in Advik Laboratories

Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company

Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma
News | May 25, 2021

Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma

The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr

Lonza reports 12% sales growth in 2020
News | January 28, 2021

Lonza reports 12% sales growth in 2020

Lonza maintained business continuity during the COVID-19 pandemic with minimal impacts to operations and supply throughout 2020.

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?

Latest Stories

Maxivision appoints Surya K as Group Head – Medical Affairs and Quality

Shreevar Kheruka appointed Managing Director at Borosil Limited

Fortis Healthcare FY26 revenue crosses Rs. 9,100 crore

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare
Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare
Dr Vidya Veldore Vice President, Clinical Operations, 4baseCare
AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX
AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX
Dushyant Sapre Founder and CEO, SwishX
Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital
Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital
Duraisamy Rajan Palani Founder and CEO, Archimedis Digital

Packaging